Advertise with fastmoving.co.za
 
 

Zara owner Inditex bounced back from a weak start to 2019, when unseasonably cold weather in southern Europe stifled sales for the Spanish fashion group.
Zara owner Inditex bounced back from a weak start to 2019, when unseasonably cold weather in southern Europe stifled sales for the Spanish fashion group.

Zara owner Inditex shakes off chill with strong second quarter start

INTERNATIONAL NEWS

By Sonya Dowsett - Jun 14th, 11:22

Zara owner Inditex bounced back from a weak start to 2019, when unseasonably cold weather in southern Europe stifled sales for the Spanish fashion group, with a strong performance in the first weeks of the second quarter. 

This contrasts with how others in the struggling apparel sector are faring, with mid-market clothing retailer Ted Baker posting a profit warning on Tuesday after Britain had its biggest fall in retail sales on record in May.

“This is particularly impressive in our view, notably in context of industry data we have so far for May,” JP Morgan said in a research note following Inditex’s results.

Shares in the Spanish group rose 1.1% to trade at €25.57, whereas Boohoo’s fell, despite the online British fashion retailer reporting robust sales, as lower margins disappointed investors.

Inditex, the world’s biggest clothing retailer and owner of Massimo Dutti, Bershka and Oysho reported net profit of €734m for the three months from February 1 to April 30, on sales up 5% at €5.93bn.

The apparel sector has been hit by out-of-season sales as savvy shoppers expect discounts and hunt for online bargains.

Sales at constant exchange rates for the first six weeks of the second quarter were up 9.5% as shoppers snapped up items such as jewel-toned blazers and long printed dresses from Zara’s spring collections.

Inditex maintained its full-year guidance of 4%-6% growth for like-for-like sales. RBC Capital Markets estimated it had booked like-for-like sales of about 6.5% during the first weeks of the second quarter, against about 2% in the first quarter.

Gross margin grew 6% year on year to 59.5% in the quarter, as foreign currency effects moved back into favour after two years of nibbling away at profitability.

Inditex generates more than half of its sales in other currencies that have to be converted back into euros when it reports. Those currencies have strengthened slightly against the euro compared with a year ago, on average, helping reported sales.

Societe Generale and Credit Suisse estimated sales at Inditex were reduced by 3.5% in 2018 by this effect, moving to a positive effect this quarter.

With the adverse foreign exchange effects removed, Inditex is under pressure to show it can deliver strong like-for-like sales without the margin dilution that has affected others.

“With less impact from foreign exchange, this will be an important year to prove the concept,” UBS said in a note.

Business Live 

Related News

US retail sales rise as households spend more
18/07/2019 - 14:16
US retail sales increased more than expected in June, pointing to strong consumer spending, which could help to blunt some of the hit on the economy from weak business investment.

Strong Asia growth boosts Richemont’s first-quarter sales
18/07/2019 - 13:38
The luxury-goods company reports a 9% year-on-year increase at constant exchange rates.

Refinery celebrates diversity with new fashion campaign
18/07/2019 - 11:39
Local fashion retailer Refinery is set to make waves across the local industry with its new spring campaign which embraces diversity, encouraging others to be unashamedly, authentically themselves.

Retail sales jump in May ahead of expected rate cuts
18/07/2019 - 09:24
South Africa’s retail sales rose more than expected in May as sales of household goods, furniture and appliances expanded quickly, a hint that pressure on consumers was easing ahead of an expected lending rate cut that may further support spending.

Cancer drugs help Johnson & Johnson raise sales outlook
17/07/2019 - 08:41
Johnson & Johnson raised its full-year sales forecast as demand for its cancer drugs Darzalex and Imbruvica helped it exceed estimates for second-quarter profit on Tuesday.